Argentina’s Cannabis Paradox: Access First, Market Later
By Robert Hoban & Ivana Sol Vigilante Argentina has built a patient-first cannabis framework with real access, but the commercial, pharmaceutical, and regulatory pieces still have not fully aligned into a cohesive market. Argentina’s cannabis progress feels exactly like that lyric: a country that wrote the roadmap before paving the roads. On paper, it is… Keep Reading